Simplex Trading, LLC Purple Biotech Ltd. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$0.78 - $1.67 $3,041 - $6,511	-3,899 Reduced 50.16%	3,874 $3,000
Q3 2023 Nov 01, 2023	SELL	$1.02 - $1.49 $1,412 - $2,063	-1,385 Reduced 15.12%	7,773 $9,000
Q2 2023 Aug 04, 2023	SELL	$1.38 - $2.05 $14,552 - $21,617	-10,545 Reduced 53.52%	9,158 $12,000
Q1 2023 Apr 27, 2023	BUY	$1.36 - $2.3 $26,796 - $45,316	19,703 New	19,703 $34,000
Q3 2022 Nov 04, 2022	BUY	$1.92 - $2.69 $6,602 - $9,250	3,439 Added 138.73%	5,918 $12,000

Q2 2022 Aug 03, 2022	BUY	$2.39 - $4.15 $5,924 - $10,287	2,479 New	2,479 $5,000
Q2 2021 Aug 12, 2021	SELL	$3.75 - $6.72 $21,506 - $38,539	-5,735 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$3.93 - $6.99 $21,894 - $38,941	5,571 Added 3396.95%	5,735 $23,000
Q4 2020 Feb 02, 2021	BUY	$3.81 - $4.73 $624 - $775	164 New	164 $0

2.64M

6.6K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $7.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.